Cargando…

An Update on Vitamin D and Disease Activity in Multiple Sclerosis

Vitamin D and its main active metabolite 1,25-dihydroxyvitamin D serve a crucial role in maintenance of a healthy calcium metabolism, yet have additional roles in immune and central nervous system cell homeostasis. Serum levels of 25-hydroxyvitamin D are a biomarker of future disease activity in pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smolders, Joost, Torkildsen, Øivind, Camu, William, Holmøy, Trygve
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890630/ https://www.ncbi.nlm.nih.gov/pubmed/31686407 http://dx.doi.org/10.1007/s40263-019-00674-8

Ejemplares similares

Extensive Multiple Sclerosis Reactivation after Switching from Fingolimod to Rituximab
por: Holmøy, Trygve, et al.
Publicado: (2018)

Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
por: Røsjø, Egil, et al.
Publicado: (2020)

Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
por: Lossius, Andreas, et al.
Publicado: (2012)

Editorial: Vitamin D in Neurological Diseases: From Pathophysiology to Therapy
por: Smolders, Joost, et al.
Publicado: (2021)

Vitamin D and Multiple Sclerosis: Correlation, Causality, and Controversy
por: Smolders, Joost
Publicado: (2010)

No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016)

Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder
por: Holmøy, Trygve, et al.
Publicado: (2020)

Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy
por: Eid, Karine, et al.
Publicado: (2022)

Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014)

Update in vitamin D and multiple sclerosis
por: Alharbi, Fatimah M.
Publicado: (2015)

Serum markers of multiple sclerosis - a new approach
por: Torkildsen, Øivind
Publicado: (2021)

Association of adverse childhood experiences with the development of multiple sclerosis
por: Eid, Karine, et al.
Publicado: (2022)

Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
por: Holmøy, Trygve, et al.
Publicado: (2013)

Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study
por: Eid, Karine, et al.
Publicado: (2021)

The Role of Vitamin D in Neuroprotection in Multiple Sclerosis: An Update
por: Sangha, Amarpreet, et al.
Publicado: (2023)

Stress-Axis Regulation by Vitamin D(3) in Multiple Sclerosis
por: Rolf, Linda, et al.
Publicado: (2018)

Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
por: Løken-Amsrud, Kristin I., et al.
Publicado: (2013)

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial
por: Holmøy, Trygve, et al.
Publicado: (2017)

Vitamin D related genetic polymorphisms affect serological response to high-dose vitamin D supplementation in multiple sclerosis
por: Mimpen, Max, et al.
Publicado: (2021)

High‐throughput sequencing of immune repertoires in multiple sclerosis
por: Lossius, Andreas, et al.
Publicado: (2016)

Vitamin D Status Is Positively Correlated with Regulatory T Cell Function in Patients with Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2009)

The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
por: Berge, T, et al.
Publicado: (2016)

Randomized trial of daily high-dose vitamin D(3) in patients with RRMS receiving subcutaneous interferon β-1a
por: Hupperts, Raymond, et al.
Publicado: (2019)

Safety and T Cell Modulating Effects of High Dose Vitamin D(3) Supplementation in Multiple Sclerosis
por: Smolders, Joost, et al.
Publicado: (2010)

Timing of use of cod liver oil, a vitamin D source, and multiple sclerosis risk: The EnvIMS study
por: Cortese, Marianna, et al.
Publicado: (2015)

Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
por: Varhaug, Kristin N., et al.
Publicado: (2019)

Vitamin D and multiple sclerosis
por: Harandi, Asghar Amini, et al.
Publicado: (2014)

Safety of breast feeding during rituximab treatment in multiple sclerosis
por: Rød, Brit Ellen, et al.
Publicado: (2023)

The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
por: Lie, Ingrid Anne, et al.
Publicado: (2022)

T-cell surveillance of the human brain in health and multiple sclerosis
por: Smolders, Joost, et al.
Publicado: (2022)

Vitamin D Status Does Not Affect Disability Progression of Patients with Multiple Sclerosis over Three Year Follow-Up
por: Muris, Anne-Hilde, et al.
Publicado: (2016)

Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
por: Beiske, Georg Anton Giæver, et al.
Publicado: (2015)

Disease activity in primary progressive multiple sclerosis: a systematic review and meta-analysis
por: Blok, Katelijn M., et al.
Publicado: (2023)

Adverse events with fatal outcome associated with alemtuzumab treatment in multiple sclerosis
por: Holmøy, Trygve, et al.
Publicado: (2019)

Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model
por: Wergeland, Stig, et al.
Publicado: (2011)

Exploring the effect of vitamin D(3) supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis
por: Rolf, Linda, et al.
Publicado: (2017)

Diffuse alveolar hemorrhage during alemtuzumab infusion in a patient with multiple sclerosis: a case report
por: Myro, Aija Zuleron, et al.
Publicado: (2018)

A One Year Follow-Up Study of Natural Killer and Dendritic Cells Activities in Multiple Sclerosis Patients Receiving Glatiramer Acetate (GA)
por: Høglund, Rune A., et al.
Publicado: (2013)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9j3c8be70phprnii6mvft8fs4e